Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St. Jude's Microny SR+ 2425T

This article was originally published in The Gray Sheet

Executive Summary

U.S. launch of the single-chamber, rate-responsive pacemaker will await future enhancements to be cleared via PMA supplement, following approval of the current version Dec. 21. Delay in approving St. Jude Medical's 1997 PMA application stems from FDA concerns relating to the device's sensor function, and the existing version is essentially obsolete without the planned improvements, the firm says. The device has been available in Europe since 1995

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014365

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel